Triazolam was administered to five psychiatric inpatients for a two-week period. This period was preceded by a one-week placebo baseline and followed by another week of placebo administration. All conditions were double blind. By the second week of active drug administration, psychopathology greatly intensified across all of the patients with the emergence of anxiety, memory impairment, confusion, paranoid ideation, and hallucinations. The drug-induced behavioral changes persisted during the initial withdrawal period, but then gradually subsided. Also following drug withdrawal, four patients showed a marked worsening of their sleeplessness for several nights.
KalesAKalesJDBixlerEOScharfMBRussekE. Hypnotic efficacy of triazolam: Sleep laboratory evaluation of intermediate term effectiveness. J Clin Pharmacol1976; 16: 399–406.
2.
MamelakMCsimaAPriceV. A comparative 25-night sleep laboratory study on the effects of quazepam and triazolam on the sleep of chronic insomniacs. J Clin Pharmacol1984; 24: 65–75.
3.
AdamKOswaldIShapiroC. Effects of loprazolam and of triazolam on sleep and overnight urinary cortisol. Psychopharmacology1984; 82: 389–94.
4.
PoitrasR. A propos d'episodes d'amnesies anterogrades associés à l'utilisation du triazolam. Union Med Can1980; 109: 427–9.
5.
RegensteinQR. Pharmacology and hypnotic efficacy of triazolam (commentary). Pharmacotherapy1983; 3: 146.
6.
RothTHartseKMSaabPGPiccionePMKramerM. The effects of flurazepam, lorazepam, triazolam on sleep and memory. Psychopharmacology1980; 70: 231–7.
7.
ShaderRIGreenblattDJ. Triazolam and anterograde amnesia: All is not well in the Z-zone (editorial). J Clin Psychopharmacol1983; 3: 273.
8.
SpinweberCLJohnsonIX. Effects of triazolam (0.5 mg) on sleep, performance, memory, and arousal threshold. Psychopharmacology1982; 76: 5–12.
9.
Van Der KroefC. Reactions to triazolam (letter). Lancet1979; 2: 526.
10.
Van Der KroefC. Het Halcion-syndrome-een iatrogene epidemie in Nederlan. T Alc Drugs1982; 8: 156–62.
11.
EinarsonTR. Hallucinations from triazolam. Drug Intell Clin Pharm1980; 14: 714–5.
12.
EinarsonTRYoderES. Triazolam psychosis—a syndrome?. Drug Intell Clin Pharm1982; 16: 330.
13.
KalesASoldatosCRBixlerEOKalesJD. Early morning insomnia with rapidly eliminated benzodiazepines. Science1983; 220: 95–7.
14.
MorganKOswaldI. Anxiety caused by a short-life hypnotic. Br Med J1982; 284: 942.
KalesAScharfMBKalesJDSoldatosCR. Rebound insomnia: A potential hazard following withdrawal of certain benzodiazepines. JAMA1979; 241: 1692–5.
17.
KalesASoldatosCRBixlerEOKalesJD. Rebound insomnia and rebound anxiety: A review. Pharmacology1983; 26: 121–37.
18.
KalesAKalesJD. Sleep laboratory studies of hypnotic drugs: Efficacy and withdrawal effects. J Clin Psychopharmacol1983; 3: 140–50.
19.
VogelGThurmondAGibbonsPEdwardsKSloanKBSextonK. The effect of triazolam on the sleep of insomniacs. Psychopharmacology1975; 47: 65–9.
20.
VogelGWBarkerKGibbonsPThurmondA. A comparison of the effects of flurazepam 30 mg and triazolam 0.5 mg on the sleep of insomniacs. Psychopharmacology1976; 47: 81–6.
21.
RothTKramerMLutzT. Intermediate use of triazolam: A sleep laboratory study. J Int Med Res1976; 4: 59–62.
22.
HollisterLE. Pharmacology and pharmacokinetics of the minor tranquilizers. Psychiatr Ann1981; 11: 26–31.
23.
PeturssonHLaderM. Dependence on tranquilizers. Maudsley monographs (Inst. of Psychiatry). London: Oxford University Press, 1984; 28.
24.
GaindRNJacobyR. Benzodiazepines causing aggression. In: GaindRNHudsonBL, eds. Current themes in psychiatry. London: Macmillan, 1978: 371–9.
25.
LaderM. Benzodiazepines: Panacea or poison?. Aust NZ J Psychiatr1981; 29: 609–17.
26.
American Psychiatric Association.Diagnostic and statistical manual of mental disorders—third edition (DMS-III). Washington DC, 1980.
27.
RothTRoehrsTAZorickFJ. Pharmacology and hypnotic efficacy of triazolam. Pharmacotherapy1983; 3: 137–48.
28.
PakesGEBrogdenRNHeelRCSpeightTMAveryGS. Triazolam: A review of its pharmacological properties and therapeutic efficacy in patients with insomnia. Drugs1981; 22: 81–110.
29.
TanTLBixlerEOKalesACadieuxRJGoodmanAL. Early morning insomnia, daytime anxiety, and organic mental disorder associated with triazolam. J Fam Pract1985; 20: 592–4.
